DNA-based
Monoclonal Antibody (Plas-mAb)

HOME > R&D > DNA-based Monoclonal Antibody (Plas-mAb)
Comparison with existing monoclonal antibody therapeutics
Advantages compared to existing monoclonal antibody therapeutics
Market size of existing monoclonal antibody therapeutics

The value of the domestic monoclonal antibody therapeutics market is forecasted to grow by 28% yearly from KRW49.9 billion in 2008 to KRW1 trillion in 2020.

The value of the global monoclonal antibody therapeutics market is estimated to grow by 14.2% yearly from US$29.2 billion in 2008 to US$88 billion in 2020.